Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience. Data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Conference, held here Nov...
More...